Honasa Consumer

Honasa Consumer Ltd recorded its highest-ever quarterly revenue of Rs 756 crore and profit after tax of Rs 90 crore for the quarter ended June 30, 2026 (Q1 FY27).

Reader Takeaway: Strong revenue and profit growth driven by diversified brands and channels, but ad spend remains high.

What just happened

Honasa Consumer reported a 27% year-on-year (YoY) increase in revenue from operations to Rs 756 crore for Q1 FY27. Profit After Tax (PAT) surged by 116.5% to Rs 90 crore compared to Rs 41 crore in Q1 FY26. EBITDA also saw a significant jump of 140.7% to Rs 110 crore, with margins expanding to 14.6% from 7.7% YoY.

Why this matters

The record results highlight Honasa Consumer's successful execution of its multi-brand and multi-channel strategy. Expansion in focus categories, like Mamaearth's rosemary products and The Derma Co's serums, along with growth in general and modern trade, signal strong market traction beyond its initial e-commerce focus.

The backstory

Honasa Consumer, known for brands like Mamaearth, has been actively expanding its portfolio and distribution network. The company has focused on scaling its profitable B2B channels and growing its offline retail presence, which has now reached approximately 3 lakh outlets.

What changes now

The company's entry into the fragrance category with the new brand 'FIKN' could open new revenue streams. Continued growth in brands like The Derma Co, which achieved INR 1,000 Cr NSV ARR, and the acquisition of BTM Ventures (Reginald Men) further diversify its business.

Risks to watch

While A&P spending grew 16.7% YoY to Rs 241 crore, it remains a significant cost. Investors should also monitor the impact of revenue recognition changes with the Flipkart group, which resulted in a difference between reported revenue (Rs 756 Cr) and Like-for-Like (LFL) revenue (Rs 785 Cr).

Peer comparison

Honasa Consumer's strong double-digit growth in revenue and significant margin expansion in Q1 FY27 contrasts with many established FMCG players who are often reporting single-digit volume growth. The company's agility in scaling brands and entering new categories sets it apart.

Context metrics (time-bound)

• Revenue: Rs 756 crore (Q1 FY27) vs Rs 595 crore (Q1 FY26) - 27% YoY growth.
• PAT: Rs 90 crore (Q1 FY27) vs Rs 41 crore (Q1 FY26) - 116.5% YoY growth.
• EBITDA Margin: 14.6% (Q1 FY27) vs 7.7% (Q1 FY26).
• Offline Reach: ~3 lakh outlets (June 2026).
• The Derma Co ARR: INR 1,000 Cr NSV (June 2026).

What to track next

Investors will be watching the performance of the new 'FIKN' fragrance brand and the continued growth trajectory of existing brands across e-commerce, general trade, and modern trade channels. The company's ability to maintain profitability while managing advertising spend will be key.